https://www.selleckchem.com/pr....oducts/pexidartinib-
Patients with esophageal cancer often experience clinically relevant deterioration of quality of life (QOL) after esophagectomy owing to malnutrition, lack of physical exercise, and psychological symptoms. This study aimed to evaluate the feasibility, safety, and efficacy of a comprehensive intervention model using a mobile health system (CIMmH) in patients with esophageal cancer after esophagectomy. Twenty patients with esophageal cancer undergoing the modified McKeown surgical procedure were invited to join the CIMmH prog
Like
Comment
Share
